Experiments in the latest oncology research regarding PRKCDBP as a transcriptional target of TNF‐α demonstrated that low expression of PRKCDBP forebode poor prognosis in tumour patients, including those with lung adenocarcinoma.42, 43. This evidence concerns the gene CAVIN3 and neoplasm.